These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 29674411)
1. Sequential Apparent Diffusion Coefficient for Assessment of Tumor Progression in Patients with Low-Grade Glioma. Chen IE; Swinburne N; Tsankova NM; Hefti MM; Aggarwal A; Doshi AH; Hormigo A; Delman BN; Nael K AJNR Am J Neuroradiol; 2018 Jun; 39(6):1039-1046. PubMed ID: 29674411 [TBL] [Abstract][Full Text] [Related]
2. Preoperative grading of supratentorial gliomas using high or standard b-value diffusion-weighted MR imaging at 3T. Cihangiroglu MM; Ozturk-Isik E; Firat Z; Kilickesmez O; Ulug AM; Ture U Diagn Interv Imaging; 2017 Mar; 98(3):261-268. PubMed ID: 28038915 [TBL] [Abstract][Full Text] [Related]
3. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868 [TBL] [Abstract][Full Text] [Related]
4. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas. Wu CC; Jain R; Radmanesh A; Poisson LM; Guo WY; Zagzag D; Snuderl M; Placantonakis DG; Golfinos J; Chi AS AJNR Am J Neuroradiol; 2018 Oct; 39(10):1814-1820. PubMed ID: 30190259 [TBL] [Abstract][Full Text] [Related]
5. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign. Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467 [TBL] [Abstract][Full Text] [Related]
6. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade. Kang Y; Choi SH; Kim YJ; Kim KG; Sohn CH; Kim JH; Yun TJ; Chang KH Radiology; 2011 Dec; 261(3):882-90. PubMed ID: 21969667 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases. Caravan I; Ciortea CA; Contis A; Lebovici A Acta Radiol; 2018 May; 59(5):599-605. PubMed ID: 28835111 [TBL] [Abstract][Full Text] [Related]
8. Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas. Rahm V; Boxheimer L; Bruehlmeier M; Berberat J; Nitzsche EU; Remonda L; Roelcke U J Nucl Med; 2014 Apr; 55(4):546-50. PubMed ID: 24566001 [TBL] [Abstract][Full Text] [Related]
9. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging. Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139 [TBL] [Abstract][Full Text] [Related]
10. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema. Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234 [TBL] [Abstract][Full Text] [Related]
11. ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma. Nowosielski M; Recheis W; Goebel G; Güler O; Tinkhauser G; Kostron H; Schocke M; Gotwald T; Stockhammer G; Hutterer M Neuroradiology; 2011 Apr; 53(4):291-302. PubMed ID: 21125399 [TBL] [Abstract][Full Text] [Related]
12. Grading of Gliomas by Using Monoexponential, Biexponential, and Stretched Exponential Diffusion-weighted MR Imaging and Diffusion Kurtosis MR Imaging. Bai Y; Lin Y; Tian J; Shi D; Cheng J; Haacke EM; Hong X; Ma B; Zhou J; Wang M Radiology; 2016 Feb; 278(2):496-504. PubMed ID: 26230975 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of apparent diffusion coefficient parameters for glioma grading. Wang Q; Zhang J; Xu X; Chen X; Xu B J Neurooncol; 2018 Aug; 139(1):61-68. PubMed ID: 29574566 [TBL] [Abstract][Full Text] [Related]
14. Perilesional apparent diffusion coefficient in the preoperative evaluation of glioma grade. Yazdani M; Rumboldt Z; Tabesh A; Giglio P; Schiarelli C; Morgan PS; Spampinato MV Clin Imaging; 2018; 52():88-94. PubMed ID: 30032069 [TBL] [Abstract][Full Text] [Related]
15. Differentiation of Low- and High-Grade Gliomas Using High b-Value Diffusion Imaging with a Non-Gaussian Diffusion Model. Sui Y; Xiong Y; Jiang J; Karaman MM; Xie KL; Zhu W; Zhou XJ AJNR Am J Neuroradiol; 2016 Sep; 37(9):1643-9. PubMed ID: 27256851 [TBL] [Abstract][Full Text] [Related]
16. Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation. Knitter JR; Erly WK; Stea BD; Lemole GM; Germano IM; Doshi AH; Nael K AJR Am J Roentgenol; 2018 Jul; 211(1):168-175. PubMed ID: 29708785 [TBL] [Abstract][Full Text] [Related]
18. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms. Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556 [TBL] [Abstract][Full Text] [Related]
19. Apparent diffusion coefficient measurement in glioma: Influence of region-of-interest determination methods on apparent diffusion coefficient values, interobserver variability, time efficiency, and diagnostic ability. Han X; Suo S; Sun Y; Zu J; Qu J; Zhou Y; Chen Z; Xu J J Magn Reson Imaging; 2017 Mar; 45(3):722-730. PubMed ID: 27527072 [TBL] [Abstract][Full Text] [Related]
20. Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC? Rose S; Fay M; Thomas P; Bourgeat P; Dowson N; Salvado O; Gal Y; Coulthard A; Crozier S AJNR Am J Neuroradiol; 2013 Apr; 34(4):758-64. PubMed ID: 23079407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]